U.S., July 2 -- ClinicalTrials.gov registry received information related to the study (NCT07046559) titled 'A Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY4066708 in Healthy Participants' on May 13.
Brief Summary: The main purpose of this study is to explore the safety and any side effects of LY4066708 in healthy participants. The study will also measure how much LY4066708 gets into the bloodstream and the central nervous system and how long it takes the body to remove it. The study will last up to 24 weeks for each participant.
Study Start Date: May 13
Study Type: INTERVENTIONAL
Condition:
Healthy
Cancer
Intervention:
DRUG: LY4066708
Administered IV
DRUG: Placebo
Admini...